307 related articles for article (PubMed ID: 1907089)
1. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Crijns HJ; Van Gelder IC; Van Gilst WH; Hillege H; Gosselink AM; Lie KI
Am J Cardiol; 1991 Aug; 68(4):335-41. PubMed ID: 1907089
[TBL] [Abstract][Full Text] [Related]
2. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
5. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.
Van Gelder IC; Crijns HJ; Van Gilst WH; Verwer R; Lie KI
Am J Cardiol; 1991 Jul; 68(1):41-6. PubMed ID: 2058558
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
Peters FP; Braat SH; Heymeriks J; Wellens HJ
Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.
Chun SH; Sager PT; Stevenson WG; Nademanee K; Middlekauff HR; Singh BN
Am J Cardiol; 1995 Jul; 76(1):47-50. PubMed ID: 7793402
[TBL] [Abstract][Full Text] [Related]
10. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
Kalusche D; Stockinger J; Betz P; Roskamm H
Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter.
Crijns HJ; van Gelder IC; Lie KI
Eur Heart J; 1994 Apr; 15 Suppl A():17-21. PubMed ID: 8070491
[TBL] [Abstract][Full Text] [Related]
12. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.
Gosselink AT; Crijns HJ; Van Gelder IC; Hillige H; Wiesfeld AC; Lie KI
JAMA; 1992 Jun; 267(24):3289-93. PubMed ID: 1597910
[TBL] [Abstract][Full Text] [Related]
13. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
[TBL] [Abstract][Full Text] [Related]
15. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
Tuinenburg AE; Van Gelder IC; Van Den Berg MP; Brügemann J; De Kam PJ; Crijns HJ
Heart; 1999 Oct; 82(4):486-93. PubMed ID: 10490566
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
Kosior D; Opolski G; Torbicki A
Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
